Skip to search boxSkip to navigationSkip to main content

Identification of estrogen signaling in a prioritization study of intraocular pressure-associated genes

  • Hannah A. Youngblood
    ,
  • Emily Parker
    ,
  • Jingwen Cai
    ,
  • Kristin Perkumas
    ,
  • Hongfang Yu
    ,
  • Jason Sun
*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Abstract

Elevated intraocular pressure (IOP) is the only modifiable risk factor for primary open-angle glaucoma (POAG). Herein we sought to prioritize a set of previously identified IOP-associated genes using novel and previously published datasets. We identified several genes for future study, including several involved in cytoskeletal/extracellular matrix reorganization, cell adhesion, angiogenesis, and TGF-β signaling. Our differential correlation analysis of IOP-associated genes identified 295 pairs of 201 genes with differential correlation. Pathway analysis identified β-estradiol as the top upstream regulator of these genes with ESR1 mediating 25 interactions. Several genes (i.e., EFEMP1, FOXC1, and SPTBN1) regulated by β-estradiol/ESR1 were highly expressed in non-glaucomatous human trabecular meshwork (TM) or Schlemm’s canal (SC) cells and specifically expressed in TM/SC cell clusters defined by single-cell RNA-sequencing. We confirmed ESR1 gene and protein expression in human TM cells and TM/SC tissue with quantitative real-time PCR and immunofluorescence, respectively. 17β-estradiol was identified in bovine, porcine, and human aqueous humor (AH) using ELISA. In conclusion, we have identified estrogen receptor signaling as a key modulator of several IOP-associated genes. The expression of ESR1 and these IOP-associated genes in TM/SC tissue and the presence of 17β-estradiol in AH supports a role for estrogen signaling in IOP regulation.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Article number

10288

Journal (Volume, Issue Number)

International journal of molecular sciences (Volume 22, Issue 19)

Publication milestones

  • Published - 10/01/2021

Publication status

Published - 10/01/2021

ISSN

1661-6596

Publication IDs

  • Scopus: 85115612418
  • PubMed: 34638643

Publication metrics

Metrics

Fractional count
3
Fractional count
0.23
Fractional count
10
Fractional count
0.77
Fractional count
3
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Captures
10
Citation count
18

Funding Details

This research was funded by the BrightFocus Foundation; Fight for Sight; The Glaucoma Foundation; the Glaucoma Research Foundation; Research to Prevent Blindness; and the National Institutes of Health, F31EY031973, P30EY005722, P30EY031631, R01EY023242, R01EY022359, R01EY023287, R01EY015473, R01EY032559, and R21EY028671. The APC was funded by R01EY023242. Acknowledgments: The authors thank all of the donors for their ocular samples. This study would not be feasible without these precious samples. The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health and by NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS. The data used for the analyses described in this manuscript were obtained from the GTEx Portal on 12/3/2018. Parts of this manuscript were presented at the 2020 ARVO Annual Meeting by Yutao Liu and the 2021 ARVO Annual Meeting by Hannah A. Youngblood. Funding: This research was funded by the BrightFocus Foundation; Fight for Sight; The Glaucoma Foundation; the Glaucoma Research Foundation; Research to Prevent Blindness; and the National Institutes of Health, F31EY031973, P30EY005722, P30EY031631, R01EY023242, R01EY022359, R01EY023287, R01EY015473, R01EY032559, and R21EY028671. The APC was funded by R01EY023242.
FundersFunding numbers
GRF
-
RPB
-
NIMH
-
NHGRI
-
NINDS
-
NCI
-
NIDA
-
NHLBI
-
FFS
-
TGF
-
BFF
-
NEI
F31EY031973, R01EY023242, R21EY028671, P30EY031631
NIH
R01EY022359, R01EY023287, R01EY032559, R01EY015473, P30EY005722